ROSEN, A LEADING LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBP

Author's Avatar
Sep 01, 2022

PR Newswire